Asia Pacific Endoscopic Retrograde Cholangiopancreatography Devices Market
Taille du marché en milliards USD
TCAC : %
Période de prévision |
2021 –2028 |
Taille du marché (année de référence) |
USD 418.33 Million |
Taille du marché (année de prévision) |
USD 689.77 Million |
TCAC |
|
Principaux acteurs du marché |
Marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique, par type de produit (dispositifs d'endothérapie, endoscopes, dispositifs d'imagerie et autres), modalité (usage unique, autonome, portable), procédure (sphictériectomie biliaire, stenting biliaire , dilatation biliaire, stenting du canal pancréatique, sphictériectomie pancréatique), application (canal biliaire, pancréas , vésicule biliaire, foie et autres), utilisateur final (hôpitaux, centre de chirurgie ambulatoire, laboratoires de diagnostic et autres), type d'établissement (grand, moyen et petit), canal de distribution (appels d'offres directs, distribution par des tiers et ventes au détail). Pays (Japon, Chine, Corée du Sud, Inde, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Vietnam, reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie 2028.
Analyse et perspectives du marché : Marché des dispositifs de cholangiopancréatographie endoscopique rétrograde en Asie-Pacifique
Le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique devrait croître au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 6,9 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 689,77 millions USD d'ici 2028 contre 418,33 millions USD en 2020. La forte prévalence des maladies pancréatiques et biliaires sera probablement le principal moteur de la demande du marché au cours de la période de prévision.
La forte prévalence des maladies pancréatiques et biliaires, l'augmentation des efforts de recherche et développement des principaux acteurs de l'industrie pour le développement de dispositifs innovants, le soutien du gouvernement et l'augmentation des infrastructures de soins de santé stimulent la croissance du marché. Cependant, l'approbation gouvernementale stricte des nouveaux dispositifs peut constituer un frein à la croissance du marché. Les méthodologies avancées présentes dans le domaine constituent également une opportunité pour le marché mondial des dispositifs de cholangiopancréatographie rétrograde endoscopique. Les effets secondaires associés à la procédure constituent un défi pour le marché.
Le rapport sur le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique fournit des détails sur la part de marché, les nouveaux développements et l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste. Notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique
Le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique est classé en sept segments notables qui sont basés sur le type de produit, la modalité, la procédure, l'application, l'utilisateur final, le type d'établissement et le canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base du type de produit, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en dispositifs d'endothérapie, endoscopes, dispositifs d'imagerie et autres. En 2021, le segment des dispositifs d'endothérapie devrait dominer le marché en raison de la disponibilité de divers types d'équipements, et de grands acteurs fabriquent ces types d'équipements sur le marché de la région Asie-Pacifique.
- Sur la base de la modalité, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en dispositifs à usage unique, autonomes et portables. En 2021, le segment à usage unique devrait dominer le marché car il n'y a aucun risque de transmission de maladie d'un patient à un autre lors de l'utilisation de dispositifs à usage unique.
- Sur la base de la procédure, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en sphinctérotomie biliaire, pose d'un stent biliaire, dilatation biliaire, pose d'un stent du canal pancréatique et sphinctérotomie pancréatique. En 2021, le segment de la sphinctérotomie biliaire devrait dominer le marché en raison de la forte prévalence des tumeurs pancréatiques dans la région Asie-Pacifique.
- Sur la base des applications, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en voies biliaires, pancréas, vésicule biliaire, foie et autres. En 2021, le segment des voies biliaires devrait dominer le marché en raison de la forte prévalence des maladies biliaires dans la région Asie-Pacifique.
- Sur la base de l'utilisateur final, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en hôpitaux, centres de chirurgie ambulatoire, laboratoires de diagnostic et autres. En 2021, le segment des hôpitaux devrait dominer le marché en raison de l'importance croissante accordée aux initiatives stratégiques (telles que les acquisitions, les partenariats et les collaborations) par les sociétés de dispositifs médicaux pour étendre leurs capacités sur le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique.
- En fonction du type d'établissement, le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique de la région Asie-Pacifique est segmenté en grandes, moyennes et petites structures. En 2021, un grand segment devrait dominer le marché en raison de la forte demande de procédures de cholangiopancréatographie rétrograde endoscopique dans les grandes structures de la région Asie-Pacifique.
- On the basis of distribution channel, the Asia-Pacific endoscopic retrograde cholangiopancreatography devices market is segmented into direct tenders, third-party distribution, and retail sales. In 2021, a direct tender segment is expected to dominate the market because of significant growth due to the overall control over sales and revenue processes and direct interactions with customers.
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Devices Market Country Level Analysis
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market is analyzed, and market size information is provided by product type, modality, procedure, applications, end user, facility type, and distribution.
The countries covered in the Asia-Pacific endoscopic retrograde cholangiopancreatography devices market report are Japan, China, India, South Korea, Australia, Singapore, Indonesia, Philippines, and Rest of Asia-Pacific.
Asia-Pacific is expected to grow with the highest CAGR in the forecasted periods. In Asia-Pacific countries, there is a surge in pancreatic and biliary diseases with increasing healthcare infrastructure. Japan is expected to dominate in the market in the Asia-Pacific market. Japan is one of the leading countries to inculcate the endoscopic retrograde cholangiopancreatography devices market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
The Presence of Advanced Technology and Strategic Initiatives Taken by Players are Creating New Opportunities in the Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Devices Market
The Asia-Pacific endoscopic retrograde cholangiopancreatography devices market provides you with a detailed market analysis for every country's growth in a particular industry with ERCP product sales, the impact of advancement, and changes in regulatory scenarios with support for the market. The data is available for the historical period 2010 to 2019.
Competitive Landscape and Europe Endoscopic Retrograde Cholangiopancreatography Devices Market Share Analysis
Le paysage concurrentiel du marché des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'ampleur du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus ne concernent que l'orientation de l'entreprise sur le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique.
Les principales sociétés fournissant des dispositifs de cholangiopancréatographie rétrograde endoscopique en Asie-Pacifique sont Olympus Corporation, Boston Scientific Corporation, Medtronic, BD, Ambu Inc., CONMED Corporation, HOBBS MEDICAL INC., FUJIFILM Corporation, TeleMed Systems Inc., Merit Medical Systems, Cook, KARL STORZ SE & Co. KG, Johnson & Johnson Services, Inc., HOYA Corporation, STERIS, Shaili Endoscopy, Hospiline Equipments, entre autres.
Les analystes DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
Les initiatives stratégiques des acteurs du marché et les nouvelles avancées technologiques pour les dispositifs de cholangiopancréatographie rétrograde endoscopique comblent le fossé entre divers traitements.
Par exemple,
- En janvier 2021, STERIS a annoncé avoir conclu un accord pour acquérir Cantel, un fournisseur mondial de produits d'endoscopie. Cette acquisition aidera l'entreprise à élargir son portefeuille de produits d'endoscopie
- En octobre 2020, Olympus Corporation a annoncé le lancement de deux dispositifs de gestion des calculs ERCP , les dispositifs d'endothérapie StoneMasterV et VorticCatrchV, qui augmenteront l'efficacité de la gestion des calculs des voies biliaires et ont aidé l'entreprise à générer davantage de revenus.
La collaboration, les coentreprises et d’autres stratégies des acteurs du marché améliorent l’impression de l’entreprise sur le marché des dispositifs de cholangiopancréatographie rétrograde endoscopique, ce qui profite également à l’organisation pour améliorer la croissance de ses ventes.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEAR CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGIONAL SUMMARY
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: REGULATIONS
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 SURGE IN PREVALENCE OF PANCREATIC AND LIVER DISORDERS
7.1.2 INCREASE IN THE GERIATRIC POPULATION
7.1.3 RISING HEALTHCARE EXPENDITURE
7.1.4 HIGH PREVALENCE OF PANCREATIC CANCER
7.2 RESTRAINTS
7.2.1 HIGH COST OF DEVICES
7.2.2 STRINGENT GOVERNMENT RULES
7.2.3 EMERGENCE OF COVID-19
7.3 OPPORTUNITIES
7.3.1 STRATEGIC INITIATIVES TAKEN BY PLAYERS
7.3.2 RISE IN ALCOHOL CONSUMPTION AND SURGE IN SMOKING
7.3.3 RISING DISPOSABLE INCOME
7.3.4 GROWING MEDICAL TOURISM
7.4 CHALLENGES
7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE
7.4.2 SHORTAGE OF SKILLED PERSONNEL
8 IMPACT OF COVID-19 ON ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY
8.4 KEY INITIATIVES BY MARKET PLAYER DURING COVID 19
8.5 CONCLUSION:
9 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 ENDOTHERAPY DEVICES
9.2.1 SPHINCTEROTOME
9.2.2 CANNULAS
9.2.3 CATHETERS
9.2.4 BALLOONS
9.2.5 LITHOTRIPTERS
9.2.6 STENTS
9.2.7 GUIDING WIRES
9.2.8 FORCEPS
9.2.9 BASKETS
9.2.10 SNARES
9.2.11 OTHERS
9.3 ENDOSCOPE
9.4 IMAGING DEVICES
9.5 OTHERS
10 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY
10.1 OVERVIEW
10.2 SINGLE USE
10.3 STANDALONE
10.4 HANDHELD
11 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE
11.1 OVERVIEW
11.2 BILIARY SPHINCTERECTOMY
11.3 BILIARY STENTING
11.4 BILIARY DILATION
11.5 PANCREATIC DUCT STENTING
11.6 PANCREATIC DUCT DILATION
11.7 PANCREATIC SPHINCTERECTOMY
12 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 BILE DUCT
12.3 PANCREAS
12.4 GALL BLADDER
12.5 LIVER
12.6 OTHERS
13 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 AMBULATORY SURGICAL CENTERS
13.4 DIAGNOSTIC LABORATORIES
13.5 OTHERS
14 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE
14.1 OVERVIEW
14.2 LARGE
14.3 MEDIUM
14.4 SMALL
15 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDERS
15.3 THIRD PARTY DISTRIBUTION
15.4 RETAIL SALES
16 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION
16.1 ASIA-PACIFIC
16.1.1 JAPAN
16.1.2 CHINA
16.1.3 SOUTH KOREA
16.1.4 INDIA
16.1.5 AUSTRALIA
16.1.6 SINGAPORE
16.1.7 THAILAND
16.1.8 MALAYSIA
16.1.9 INDONESIA
16.1.10 PHILIPPINES
16.1.11 REST OF ASIA-PACIFIC
17 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 OLYMPUS CORPORATION
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 BOSTON SCIENTIFIC CORPORATION
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 STERIS
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 FUJIFILM CORPORATION
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 BD
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENTS
19.6 MEDTRONIC
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 JOHNSON & JOHNSON SERVICES, INC.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 AMBU INC.
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENTS
19.9 CONMED CORPORATION
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 COOK
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 HOBBS MEDICAL INC.
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 HOSPILINE EQUIPMENTS
19.12.1 COMPANY SNAPSHOT
19.12.2 PRODUCT PORTFOLIO
19.12.3 RECENT DEVELOPMENT
19.13 HOYA CORPORATION
19.13.1 COMPANY SNAPSHOT
19.13.2 REVENUE ANALYSIS
19.13.3 PRODUCT PORTFOLIO
19.13.4 RECENT DEVELOPMENT
19.14 KARL STORZ SE & CO. KG
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENTS
19.15 MEDI-GLOBE GMBH
19.15.1 COMPANY SNAPSHOT
19.15.2 PRODUCT PORTFOLIO
19.15.3 RECENT DEVELOPMENT
19.16 MERIT MEDICAL SYSTEMS
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENT
19.17 SHAILI ENDOSCOPY
19.17.1 COMPANY SNAPSHOT
19.17.2 PRODUCT PORTFOLIO
19.17.3 RECENT DEVELOPMENT
19.18 TELEMED SYSTEMS, INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 PRODUCT PORTFOLIO
19.18.3 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
Liste des tableaux
TABLE 1 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 2 ASIA-PACIFIC ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 ASIA-PACIFIC ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC ENDOSCOPE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC IMAGING DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC SINGLE USE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC STANDALONE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC HANDHELD IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC BILIARY SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC BILIARY STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC BILIARY DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC PANCREATIC DUCT STENTING IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC PANCREATIC DUCT DILATION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC PANCREATIC SPHINCTERECTOMY IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC BILE DUCT IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC PANCREAS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC GALL BLADDER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC LIVER IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC HOSPITALS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC DIAGNOSTIC LABORATORIES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC OTHERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC LARGE IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC MEDIUM IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC SMALL IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC DIRECT TENDERS IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC THIRD PARTY DISTRIBUTION IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC RETAIL SALES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 46 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 47 JAPAN ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 49 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 50 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 53 JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 55 CHINA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 58 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 61 CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 63 SOUTH KOREA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 65 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 66 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 68 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 69 SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 71 INDIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 73 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 74 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 76 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 77 INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 78 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 79 AUSTRALIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 81 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 82 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 84 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 85 AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 86 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 87 SINGAPORE ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 89 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 90 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 93 SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 94 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 95 THAILAND ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 96 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 97 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 98 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 99 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 100 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 101 THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 102 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 103 MALAYSIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 104 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 105 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 106 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 107 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 108 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 109 MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 110 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 111 INDONESIA ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 112 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 113 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 114 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 115 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 116 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 117 INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 118 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 119 PHILIPPINES ENDOTHERAPY DEVICES IN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 120 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 121 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
TABLE 122 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 123 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 124 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY FACILITY TYPE, 2019-2028 (USD MILLION)
TABLE 125 PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 126 REST OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
Liste des figures
FIGURE 1 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SEGMENTATION
FIGURE 11 THE HIGH PREVALENCE OF PANCREATIC AND BILIARY DISEASES IS EXPECTED TO DRIVE THE ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ENDOTHERAPY DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET
FIGURE 14 PANCREATIC CANCER MORTALITY, BY REGION (2020)
FIGURE 15 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2020
FIGURE 16 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 17 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 18 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2020
FIGURE 20 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 21 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 22 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 23 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2020
FIGURE 24 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)
FIGURE 25 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)
FIGURE 26 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE
FIGURE 27 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2020
FIGURE 28 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 29 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 30 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 31 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2020
FIGURE 32 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 33 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, CAGR (2021-2028)
FIGURE 34 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2020
FIGURE 36 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, 2021-2028 (USD MILLION)
FIGURE 37 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, CAGR (2021-2028)
FIGURE 38 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY FACILITY TYPE, LIFELINE CURVE
FIGURE 39 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 40 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 41 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 42 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 43 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: SNAPSHOT (2020)
FIGURE 44 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020)
FIGURE 45 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 46 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 48 ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICES MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.